The most succinct explanation for the distribution of tau and Aβ pathologies in AD is a progression that begins with tau pathology in the ECH, followed by Aβ deposition in the isocortex, and ends with the gradual propagation of tau pathology to the isocortex. This evidence concerns the gene MAPT and Alzheimer disease.